
GLENVIEW CAPITAL MANAGEMENT, LLC is an institutional investment manager that files quarterly 13F reports with the SEC. As of Q1 2026, the fund manages $4.0B in reported equity holdings across 43 positions. The largest holdings are CVS (14.8%), GPN (10.9%), THC (7.2%), AMZN (5.5%), TEVA (5.0%). The portfolio is concentrated in Other (72.1%), Healthcare (18.4%), Communication Services (4.5%). Data sourced from SEC EDGAR 13F filings (CIK 1138995).
